Page 44 - CIBERBBN-2015-eng
P. 44
Research groups
Ocular Surface Inflammation
& Advanced Therapies Groups
Programme: Biomaterials & Advanced Therapies Lead Researcher: Calonge Cano, Margarita
Group members
STAFF MEMBERS: Fernández Martínez, Itziar | Nieto Miguel, Teresa.
ASSOCIATED MEMBERS: Diebold Luque, Yolanda | Enríquez de Salamanca Aladro, Amalia | González
García, María Jesús | Herreras Cantalapiedra, José María | Iglesias Muñoz, Francisco Javier.
CONTRIBUTORS: Corell Almuzara, Alfredo | Galindo de la Rosa, Sara | López Paniagua, Marina | Reinoso Tapia, Roberto | Soriano Romani, Laura.
Main lines of research
VERTICAL RESEARCH LINES:
• Advances therapies.Target diseases: Corneal blindness caused by limbal stem cell deficiency. Field of research: Cell therapy, Tissue engineer- ing, Clinical Trials.
• Inflammation. Target diseases: Dry Eye Syn- drome, Allergy, Other immune-based diseases. Field of research: In vitro models, Biomarkers and new therapies, Environmental stress, Contact lenses.
• Nanomedicine. Target diseases: Dry Eye Syn- drome, Allergy, Other immune-based diseases. Field of research: Drug delivery systems, Gene therapy, Gene silencing.
HORIZONTAL RESEARCH LINES:
• Physiology and Immunology. Field of research: Characterization of eye associated lymphoid tis- sue in health and disease.
• Clinical trials. Target disease: Ocular surface in- flammation, Limbal stem cell deficiency, Intraoc- ular inflammation (Uveítis), Contact lens-associ- ated pathologies. Field of research: Cell therapy, Drug therapy, Contact lenses.
44 I Annual report 2015 I CIBER-BBN
